Filter
1398
Text search:
Tuberculosis
treatment
success
rates
Featured
Recommendations
116
New Publications
439
Language
Document type
No document type
950
Studies & Reports
218
Guidelines
113
Strategic & Response Plan
45
Manuals
43
Training Material
11
Fact sheets
8
Situation Updates
4
Infographics
4
Resource Platforms
2
Countries / Regions
India
59
Global
49
Kenya
47
Western and Central Europe
44
Nigeria
36
Zambia
35
South Africa
32
Ethiopia
31
Tanzania
31
Rwanda
31
Uganda
30
Nepal
27
Bangladesh
27
Sierra Leone
25
Namibia
24
Eastern Europe
24
Malawi
22
Asia
22
Myanmar / Burma
21
Ghana
20
Latin America and the Carribbean
20
Africa
19
Liberia
18
Lesotho
18
South–East Asia Region
16
Cambodia
14
Botswana
11
Philippines
10
Zimbabwe
9
Senegal
8
Mozambique
8
East and Southern Africa
8
Ukraine
7
Pakistan
6
Indonesia
6
Haiti
5
South Sudan
5
Germany
5
Sudan
5
Georgia
5
Congo, Democratic Republic of
4
Jordan
4
Eswatini/ Swaziland
4
Albania
4
Timor Leste/ East Timor
4
Tajikistan
4
Russia
4
Guinea
3
Cameroon
3
Afghanistan
3
Lebanon
3
Syria
3
Thailand
3
Benin
3
Western Pacific Region
3
Burkina Faso
2
Saudi Arabia
2
Somalia
2
Iraq
2
Peru
2
Colombia
2
El Salvador
2
Sri Lanka
2
West and Central Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Paraguay
2
Bhutan
2
Laos
2
Moldova
2
Iran
2
Vietnam
2
Mali
1
Morocco
1
Egypt
1
China
1
Central African Republic
1
Argentina
1
Dominican Republic
1
Honduras
1
Greece
1
Libya
1
Guatemala
1
Nicaragua
1
Yemen
1
Venezuela
1
Palestine
1
North Korea
1
Djibouti
1
Armenia
1
Qatar
1
North America
1
Gabon
1
Tunisia
1
United Kingdom
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
608
Clinical Guidelines
86
Public Health
85
Women & Child Health
41
Key Resources
40
Capacity Building
17
Pharmacy & Technologies
12
Annual Report MEDBOX
1
Toolboxes
TB
269
HIV
230
AMR
45
NTDs
34
Mental Health
31
Global Health Education
29
COVID-19
27
NCDs
23
Planetary Health
22
Malaria
21
Caregiver
20
Health Financing Toolbox
17
Conflict
14
Pharmacy
14
Polio
11
Rapid Response
11
Refugee
11
Disability
10
2.0 Rapid Response
8
Ebola & Marburg
6
Natural Hazards
3
Social Ethics
2
Cholera
1
Specific Hazards
1
In Paraguay, 1.8% of the population are indigenous people. The Maká community
29 mainly live in urbanized areas in the Central Region. This study focuses on the epidemiology
30 of tuberculosis (TB) among indigenous Maká and the non-indigenous pe
...
Diagnosis and Treatment Outcomes of Tuberculosis in Relation to Gender and HIV Status in South Benin
Journal of Tuberculosis Research, 2017, 5, 189-200
Background: In Benin, little is known about the influence of both gender and
HIV-status on diagnostic patterns and treatment outcomes of
...
Tuberculosis (TB) prevention is essential for reaching the End TB targets in the South-East Asia Region (SEAR) of World Health Organization (WHO)1. The targets of 80% reduction in TB incidence rate and 90% reduction in TB mortality by 2030 (compared
...
Zambia has completed the implementation of the National TB Strategic Plan (2017-2021) that set in motion the TB elimination agenda in Zambia through coordinated and accelerated TB response. During this period, the National TB and Leprosy Programme (NTLP) registered tremendous
...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the
...
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National T
...
Investigación original / Original research
Panam Salud Publica. 2016;39(1):38–43.
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
Antimicrobial Resistance and Infection Control 2014,3 :31
Medicina (Kaunas) 2013;49(7):335-40
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evi
...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral
...
4th edition. This is fourth edition of Treatment of tuberculosis: guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promote
...